from
TF Market Research9 page report
published Oct 26, 2006
Price
$360.00 available for immediate download
This report is also available for purchase on a
per-page basis.
Report Overview
Purchase by Section
Search Inside
About
TF Market Research
...Epeius Biotechnologies Corporation is a biopharmaceutical company focused on research, development, and commercialization of the first truly effective targeted delivery system (TDS). The company's mission is to develop and commercialize its proprietary targeting technologies. Epeius core technology is TDS technology which can be injected directly into a vein and deliver genes and/or molecular therapeutics preferentially to cancerous tumors that have spread throughout the body (metastatic cancer), without eliciting systemic side effects or organ damage. These features make the targeted vectors more effective and less toxic than conventional medicines. Targeted gene delivery is the one of the primary applications of the TDS technology, is considered to be the holy grail of gene therapy. The company's technology resolves the problem of targeted gene delivery and ushers modern medicine across that threshold. Epeius' Pathotropic TDS technology represents an enabling platform technology...
|
| Source: | LIFE SCIENCE ANALYTICS
|
| Company: | EPEIUS BIOTECHNOLOGIES CORP
|
| Geographic Regions: | CALIFORNIA (STATE OF), NORTH AMERICA, PACIFIC STATES REGION, UNITED STATES OF AMERICA
|
| Format: | | PDF |  |
|
TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.
